Activity
-
Excited to attend the 5th Annual Gene Therapy Analytical Development Conference in London! Come and talk to me about how our CMC and regulatory…
Excited to attend the 5th Annual Gene Therapy Analytical Development Conference in London! Come and talk to me about how our CMC and regulatory…
Liked by Pam Dhadda
-
Here is my big news – 3 months ago I made the decision to go independent and, as of today, I am now able to offer my consultancy services in cell and…
Here is my big news – 3 months ago I made the decision to go independent and, as of today, I am now able to offer my consultancy services in cell and…
Liked by Pam Dhadda
-
The Cell and Gene Therapy Catapult (CGT Catapult) today announces that its Braintree Manufacturing Innovation Centre (Braintree MIC) has successfully…
The Cell and Gene Therapy Catapult (CGT Catapult) today announces that its Braintree Manufacturing Innovation Centre (Braintree MIC) has successfully…
Liked by Pam Dhadda
Experience & Education
-
Cencora Pharmalex
View Pam’s full experience
See their title, tenure and more.
or
Volunteer Experience
Languages
-
English
-
More activity by Pam
-
Dear friends and colleagues, today is my last day in full time employment. I am stepping down as CEO and director of Leaf Expression Systems and…
Dear friends and colleagues, today is my last day in full time employment. I am stepping down as CEO and director of Leaf Expression Systems and…
Liked by Pam Dhadda
-
The Cell and Gene Therapy Catapult conduct an annual ATMP GMP Manufacturing survey to identify the capability and capacity of MHRA licensed cell and…
The Cell and Gene Therapy Catapult conduct an annual ATMP GMP Manufacturing survey to identify the capability and capacity of MHRA licensed cell and…
Liked by Pam Dhadda
-
**post update** Dear all, thank you ever so much for the well wishes. I so very much appreciate it, and hope to connect with everyone as time…
**post update** Dear all, thank you ever so much for the well wishes. I so very much appreciate it, and hope to connect with everyone as time…
Liked by Pam Dhadda
-
I am happy to share that our article on starting materials of biological origin has been published in the September edition of TOPRA.
I am happy to share that our article on starting materials of biological origin has been published in the September edition of TOPRA.
Liked by Pam Dhadda
-
Over the past year, we have been busy building Alder Therapeutics and are excited to be emerging from stealth mode into the next stage of…
Over the past year, we have been busy building Alder Therapeutics and are excited to be emerging from stealth mode into the next stage of…
Liked by Pam Dhadda
-
Kate Fynes, CMC translation consultant at eXmoor Pharma, is full of passion, drive and optimism. Discouraged by the lack of support networks for…
Kate Fynes, CMC translation consultant at eXmoor Pharma, is full of passion, drive and optimism. Discouraged by the lack of support networks for…
Liked by Pam Dhadda
-
Seven years! it seems like only yesterday that I ventured from Kuala Lumpur to London to join ERA Consulting GmbH as Chief Operating Officer. Since…
Seven years! it seems like only yesterday that I ventured from Kuala Lumpur to London to join ERA Consulting GmbH as Chief Operating Officer. Since…
Liked by Pam Dhadda
-
💬 “My dad was diagnosed with type 2 diabetes in Nigeria when he was 70. He managed to live about five more years before he died from complications…
💬 “My dad was diagnosed with type 2 diabetes in Nigeria when he was 70. He managed to live about five more years before he died from complications…
Liked by Pam Dhadda
-
Lots of discussion of what constitutes 'suitable donor material' for off the shelf iPSC therapeutics at #ISCT2022. QbD approach, beginning with the…
Lots of discussion of what constitutes 'suitable donor material' for off the shelf iPSC therapeutics at #ISCT2022. QbD approach, beginning with the…
Liked by Pam Dhadda
-
Happy to present the results of our latest clinical research: “Daily oral supplementation with collagen peptides and other bioactive compounds has a…
Happy to present the results of our latest clinical research: “Daily oral supplementation with collagen peptides and other bioactive compounds has a…
Liked by Pam Dhadda
Other similar profiles
-
Shiv Nanda
Stem Cell & Regenerative Therapies: From Bench to Market (MSc)
Connect -
Irina Petrova
Director, clinical operations в OCT-Clinical Trials in Central and Eastern Europe
Connect -
Donna Rigg
Client Services Manager
Connect -
Kim G. Hankey
Connect -
Martin Toth
Pre-press studio Graphic Designer
Connect -
Rasa L.
Export Sales Manager
Connect -
Sarka Dellar
Connect -
Angela Thornton
Connect -
Kate Lamb
Studying CIPD Level 5
Connect -
Salvatore DiBartolo III, PhD
Scientific Consultant | Specializing in Cell Biology, Genomics, & Translational Research | Single-cell sequencing & Laboratory Management
Connect
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Pam Dhadda
2 others named Pam Dhadda are on LinkedIn
See others named Pam Dhadda